Live feed15:00:00·30dPRReleasevia QuantisnowOorja Bio Launches as a Clinical-Stage Company to Develop Groundbreaking Therapies for Idiopathic Pulmonary Fibrosis (IPF) and Other Fibrotic DiseasesByQuantisnow·Wall Street's wire, on your screen.DNTH· Dianthus Therapeutics Inc.Health Care